Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Lancet (London, England)|April 23, 1988
Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individualsK J Weinhold, H K Lyerly, T J Matthews, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1990
Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defectsD S Tyler, S D Stanley, C A Nastala, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 13, 2015
Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45)X Wang, J Ren, J Zhang, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1987
Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cellsJ R Rusche, D L Lynn, M Robert-Guroff, et al.Nature Communications|June 13, 2022
Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinomaClare A Rebbeck, Jian Xian, Susanne Bornelöv, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 31, 2018
Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS)Y Zhao, G Qiao, X Wang, et al.Lancet (London, England)|March 15, 1986
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complexR Yarchoan, R W Klecker, K J Weinhold, et al.Vaccine|October 18, 2011
Increasing vaccine potency through exosome antigen targetingZachary C Hartman, Junping Wei, Oliver K Glass, et al.BMC Immunology|March 28, 2008
Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptidesHolden T Maecker, Jeffrey Hassler, Janice K Payne, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancerM A Morse, S Nair, M Fernandez-Casal, et al.Pageof 10